Insulin resistance and pancreatic beta-cell function in patients with hypertensive kidney disease

Nephrology Dialysis Transplantation

Volumn 19, Issue 8, 2004, Pages 2025-2029

  Kanauchi, Masao ^a   Kimura, Kuniko ^a   Akai, Yasuhiro ^a   Saito, Yoshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hypertensive kidney disease; Insulin resistance; Insulin sensitivity indexes

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION, RENAL; INSULIN RESISTANCE; ISLETS OF LANGERHANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED;

EID: 4344616559     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh294     Document Type: Article

References (26)

1. Valderrabano F, Gomez-Campdera F, Jones EH. Hypertension as cause of end-stage renal disease. Kidney Int 1998; 68: S60-S66
2. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-2219
3. Ferrannini E, Buzzigoli G, Bonadonna R et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357
4. DeFronzo RA, Alvestrand A, Smith D, Hendler R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 67: 563-568
5. Schmitz O, Alberti KGMM, Christensen NJ et al. Aspects of glucose homeostasis in uremia as assessed by the hyperinsulinemic euglycemic clamp technique. Metabolism 1985; 34: 465-473
6. Alvestrand A, Mujagic M, Wajngot A, Efendic S. Glucose intolerance in uremic patients. The relative contributions of impaired beta-cell function and insulin resistance. Clin Nephrol 1989; 31: 175-183
7. Eidemak I, Feldt-Rasmussen B, Kanstrup IL, Nielsen SL, Schmitz O, Strandgaard S. Insulin resistance and hyperinsulinemia in mild to moderate progressive chronic renal failure and its association with aerobic work capacity. Diabetologia 1995; 38: 565-572
8. Vareesangthip K, Tong P, Wilkinson R, Thomas TH. Insulin resistance in adult polycystic kidney disease. Kidney Int 1997; 52: 503-508
9. Fliser D, Pacini G, Engelleiter R et al. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int 1998; 53: 1343-1347
10. National Kidney Foundation Kidney Disease Outcome Quality Initiative (K/DOQI) Advisory Board. K/DOQI clinical practice guidelines for chronic kidney disease. Am J Kidney Dis 2002; 39 [Suppl 2]: S32-S33
11. Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end-stage renal disease due to hypertension. Am J Kidney Dis 1994; 23: 655-660
12. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41
13. Kosaka K, Kuzuya T, Hagura R, Yoshinaga H. Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus. Diabetic Med 1996; 13: S109-S119
14. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. Diabetologia 1985; 28: 412-419
15. Stumvoll M, Mitrakou A, Pimenta W et al. Use of oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301
16. Gutt M, Davis CL, Spitzer SB et al. Validation of the insulin sensitivity index comparison with other measures. Diabetes Res Clin Pract 2000; 47: 177-184
17. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001; 24: 539-548
18. Paolisso G, Tagliamonte MR, Rizzo MR, Giugliano D. Advancing age and insulin resistance. Eur J Clin Invest 1999; 29: 758-769
19. Ferrannini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U. Insulin action and age. Diabetes 1996; 45: 947-953
20. Egan BM. Insulin resistance and the sympathetic nervous system. Curr Hypertens Rep 2003; 5: 247-254
21. Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG. Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens 2002; 20: 3-9
22. Vikse BE, Aasarod K, Bostad L, Iversen BN. Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrol Dial Transplant 2003; 18: 517-523
23. Wright JT,Jr, Bakris G, Green T et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. JAMA 2002; 19: 2421-2431
24. Yoneda H, Ikegami H, Yamamoto Y et al. Analysis of early-phase insulin responses in nonobese subjects with mild glucose intolerance. Diabetes Care 1992; 15: 1517-1521
25. Kanauchi M, Tsujimoto N, Hashimoto T. Validation of simple indices to assess insulin sensitivity based on the oral glucose tolerance test in the Japanese population. Diabetes Res Clin Pract 2002; 55: 229-235
26. Kanauchi M. Validation of the oral glucose insulin sensitivity index to assess insulin sensitivity in Japanese subjects for use in clinical practice. Eur J Clin Invest 2003; 33: 1022-1023